AAAAAA

   
Results: 1-14 |
Results: 14
PHARMACOKINETICS OF ORAL MIDAZOLAM IN PEDIATRIC-PATIENTS
Authors: AKBARI B KHOO KC BARSANTI F POU S PISCITELLI D GILLESPIE WR
Citation: B. Akbari et al., PHARMACOKINETICS OF ORAL MIDAZOLAM IN PEDIATRIC-PATIENTS, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 90-90
TRUNCATED SIGMOID E-MAX MODELS - A REPARAMETERIZATION OF THE SIGMOID E-MAX MODEL FOR USE WITH TRUNCATED PK PD DATA/
Authors: BACHMAN WJ GILLESPIE WR
Citation: Wj. Bachman et Wr. Gillespie, TRUNCATED SIGMOID E-MAX MODELS - A REPARAMETERIZATION OF THE SIGMOID E-MAX MODEL FOR USE WITH TRUNCATED PK PD DATA/, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 108-108
NEW MATHEMATICAL IMPLEMENTATION OF GENERALIZED PHARMACODYNAMIC MODELS- METHOD AND CLINICAL-EVALUATION
Authors: STAGNI G SHEPHERD AMM LJU YJ GILLESPIE WR
Citation: G. Stagni et al., NEW MATHEMATICAL IMPLEMENTATION OF GENERALIZED PHARMACODYNAMIC MODELS- METHOD AND CLINICAL-EVALUATION, Journal of pharmacokinetics and biopharmaceutics, 25(3), 1997, pp. 313-348
BIOAVAILABILITY ASSESSMENT FROM PHARMACOLOGICAL DATA - METHOD AND CLINICAL-EVALUATION
Authors: STAGNI G SHEPHERD AMM LIU Y GILLESPIE WR
Citation: G. Stagni et al., BIOAVAILABILITY ASSESSMENT FROM PHARMACOLOGICAL DATA - METHOD AND CLINICAL-EVALUATION, Journal of pharmacokinetics and biopharmaceutics, 25(3), 1997, pp. 349-362
VOLUMES OF DISTRIBUTION AND MEAN RESIDENCE TIME OF DRUGS WITH LINEAR TISSUE DISTRIBUTION AND BINDING AND NONLINEAR PROTEIN-BINDING
Authors: CHENG HY GILLESPIE WR
Citation: Hy. Cheng et Wr. Gillespie, VOLUMES OF DISTRIBUTION AND MEAN RESIDENCE TIME OF DRUGS WITH LINEAR TISSUE DISTRIBUTION AND BINDING AND NONLINEAR PROTEIN-BINDING, Journal of pharmacokinetics and biopharmaceutics, 24(4), 1996, pp. 389-402
SIMULTANEOUS ANALYSIS OF VERAPAMIL AND NORVERAPAMIL ENANTIOMERS IN HUMAN PLASMA BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY
Authors: STAGNI G GILLESPIE WR
Citation: G. Stagni et Wr. Gillespie, SIMULTANEOUS ANALYSIS OF VERAPAMIL AND NORVERAPAMIL ENANTIOMERS IN HUMAN PLASMA BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY, Journal of chromatography B. Biomedical applications, 667(2), 1995, pp. 349-354
PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODELING AS A TOOL FOR DRUG DEVELOPMENT - COMMENTARY
Authors: LUDDEN TM GILLESPIE WR BACHMAN WJ
Citation: Tm. Ludden et al., PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODELING AS A TOOL FOR DRUG DEVELOPMENT - COMMENTARY, Journal of pharmacokinetics and biopharmaceutics, 23(2), 1995, pp. 231-235
BIOAVAILABILITY (BA) ASSESSMENT FROM PHARMACOLOGICAL DATA - METHOD AND CLINICAL-EVALUATION
Authors: STAGNI G SHEPHERD AMM LIU Y GILLESPIE WR
Citation: G. Stagni et al., BIOAVAILABILITY (BA) ASSESSMENT FROM PHARMACOLOGICAL DATA - METHOD AND CLINICAL-EVALUATION, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 214-214
MEAN RESIDENCE TIME CONCEPTS FOR NONLINEAR PHARMACOKINETIC SYSTEMS
Authors: CHENG HY GILLESPIE WR JUSKO WJ
Citation: Hy. Cheng et al., MEAN RESIDENCE TIME CONCEPTS FOR NONLINEAR PHARMACOKINETIC SYSTEMS, Biopharmaceutics & drug disposition, 15(8), 1994, pp. 627-641
GENERALIZED PHARMACODYNAMIC MODELING - CHARACTERIZATION AND PREDICTION OF THE CARDIOVASCULAR EFFECTS OF VERAPAMIL IN RELATION TO THE INPUT-RATE
Authors: STAGNI G SHEPHERD AMM LIU Y GILLESPIE WR
Citation: G. Stagni et al., GENERALIZED PHARMACODYNAMIC MODELING - CHARACTERIZATION AND PREDICTION OF THE CARDIOVASCULAR EFFECTS OF VERAPAMIL IN RELATION TO THE INPUT-RATE, Clinical pharmacology and therapeutics, 55(2), 1994, pp. 144-144
A PHYSIOLOGICAL AND SYSTEM-ANALYSIS HYBRID PHARMACOKINETIC MODEL TO CHARACTERIZE CARBON-TETRACHLORIDE BLOOD-CONCENTRATIONS FOLLOWING ADMINISTRATION IN DIFFERENT ORAL VEHICLES
Authors: GALLO JM CHEUNG LL KIM HJ BRUCKNER JV GILLESPIE WR
Citation: Jm. Gallo et al., A PHYSIOLOGICAL AND SYSTEM-ANALYSIS HYBRID PHARMACOKINETIC MODEL TO CHARACTERIZE CARBON-TETRACHLORIDE BLOOD-CONCENTRATIONS FOLLOWING ADMINISTRATION IN DIFFERENT ORAL VEHICLES, Journal of pharmacokinetics and biopharmaceutics, 21(5), 1993, pp. 571-574
GENERALIZED PHARMACOKINETIC MODELING FOR DRUGS WITH NONLINEAR BINDING.1. THEORETICAL FRAMEWORK
Authors: GILLESPIE WR
Citation: Wr. Gillespie, GENERALIZED PHARMACOKINETIC MODELING FOR DRUGS WITH NONLINEAR BINDING.1. THEORETICAL FRAMEWORK, Journal of pharmacokinetics and biopharmaceutics, 21(1), 1993, pp. 99-124
A MULTIDIMENSIONAL DECONVOLUTION METHOD FOR EVALUATING THE ABSORPTIONOF DRUGS UNDERGOING REVERSIBLE METABOLISM AND PRESYSTEMIC METABOLITE FORMATION
Authors: GILLESPIE WR CHENG HY
Citation: Wr. Gillespie et Hy. Cheng, A MULTIDIMENSIONAL DECONVOLUTION METHOD FOR EVALUATING THE ABSORPTIONOF DRUGS UNDERGOING REVERSIBLE METABOLISM AND PRESYSTEMIC METABOLITE FORMATION, Journal of pharmaceutical sciences, 82(11), 1993, pp. 1085-1089
GENERALIZED PHARMACODYNAMIC MODELING - KINETIC CHARACTERIZATION AND PREDICTION OF THE CARDIOVASCULAR EFFECTS OF VERAPAMIL
Authors: STAGNI G SHEPHERD AMM LIU Y GILLESPIE WR
Citation: G. Stagni et al., GENERALIZED PHARMACODYNAMIC MODELING - KINETIC CHARACTERIZATION AND PREDICTION OF THE CARDIOVASCULAR EFFECTS OF VERAPAMIL, Clinical research, 41(4), 1993, pp. 10000758-10000758
Risultati: 1-14 |